Tasir Haque, PhD

Tasir Haque PhD Headshot.png

Dr. Tasir Haque is President of Sciventive, LLC and is consulting Head of Chemistry at Context Therapeutics.  Prior to joining Context, Tas was a Principal Scientist in Immunology Chemistry at Bristol-Myers Squibb, where he focused on advancing small molecule programs to IND status. His background at BMS includes drug discovery programs in several therapeutic areas including Oncology, Metabolic Diseases, and Cardiovascular Diseases. Tas has extensive experience with both small molecule and linear and cyclic peptide research. Earlier in his career, Tas was a member of the Directed Parallel Synthesis medicinal chemistry team at DuPont Pharmaceuticals, where he focused on Anti-Infectives. Tas is an inventor on multiple patents and has written and reviewed articles in several peer-reviewed journals. He holds a B.S. in Chemistry from the University of Michigan, a Ph.D. in Organic Chemistry from the University of Wisconsin, and was an NIH postdoctoral fellow at the University of California, Berkeley.